Navigation Links
Legal and ethical issues in medical physics
Date:7/18/2008

involving sexual harassment, student discrimination, and substance abuse.

Serago's talk, "Civil Law, Ethics and the Medical Physicist" (TU-D-350-2) will be at 1:30 p.m. on Tuesday, July 29 in Room 350. Abstract: http://www.aapm.org/meetings/amos2/pdf/35-9897-54661-708.pdf

5) PROFESSIONAL TRAINING: ARE MEDICAL PHYSICISTS PREPARED FOR WORKPLACE POLITICS?

Medical physicists are important in clinical decision-making, but unlike the doctors and other medical personnel who treat patients, they have not historically been required to receive formal, standardized clinical training before becoming certified. As a result, they often apply the same analytical tools taught in school to the messy politics of a modern hospital setting. A special panel will discuss how this sometimes goes badly and what medical physicists can do to comport themselves more professionally.

Although they deal with some of the most complex procedures in all of medicine, the training of medical physicists has never been completely formalized, as many of its practitioners come to it indirectly through scientific research. In contrast, medical doctors are required not only to learn the skills of their profession, but also spend time as a resident, seeing how the actual business of being a doctor is performed.

Without this sort of training, medical physicists may tend to rely too heavily on their problem-solving skills when interacting with their peers. This can lead to a medical physicist being overlooked by hospital administrators and doctors who may prize their colleague's technical knowledge but feel he or she does not have a full grasp of the big picture. However, sidelining medical physicists in this way can hurt a hospital, especially when important decisions about equipment purchases and optimization are made without the input of their expertise.

This may change a
'/>"/>

Contact: Jason Bardi
jbardi@aip.org
301-209-3091
American Institute of Physics
Source:Eurekalert

Page: 1 2 3 4 5 6 7

Related medicine news :

1. LegalView Reveals Details of the FDA Mandated Black Box Warning For Fluoroquinolone Antibiotics Such as Cipro and Levaquin
2. Blue Cross Blue Shield of Michigan Responds to Attorney Generals Complaint, Says Transaction Was Legal and Fully Authorized
3. CA Legislatures Reform of Health Insurance Cancellations Resembles Insurance Industrys Own Plan; Insurers, Satisfied With Getting a Legal Edge Against Patients, Drop Opposition to the Bill
4. PacifiCare Rescission Settlement Gives Lip Service to Patient Losses But Stacks Legal Deck in Favor of Insurers
5. Consumer Watchdog Warns HMO Regulator Not to Side With Insurers Over Illegal Coverage Cancellations
6. CNA/NNOC Wins Key Legal Decision Protecting Right of Public Employees to Strike
7. Statement of SEIU President Andy Stern Regarding UHW-Ws Confirmation of Illegal Delegate Election Process
8. Consumer Watchdog Gives HMO Regulator 10 Days to Order Reinstatement of Patients Whose Policies Have Been Illegally Cancelled
9. Legal Aid Provides Access to Justice for Victims of Violent Crime
10. Medical Records Institute (MRI) Develops Initiative for EMRs Supporting Medicolegal Requirements
11. Leading Life Sciences Company Installs SafeMedias Network Security Management Appliance to Prevent Illegal Peer to Peer (P2P) File Sharing
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Mach 7 Technologies Contracted by Singapore General Hospital to Provide State-of-the-Art Patient Image Management Technology 2Mach 7 Technologies Contracted by Singapore General Hospital to Provide State-of-the-Art Patient Image Management Technology 3BMP Sunstone Announces the Inclusion of Seventy Eight Drugs in China's National Insurance Catalog 2BMP Sunstone Announces the Inclusion of Seventy Eight Drugs in China's National Insurance Catalog 3Elsevier Selects BrainTrack Directory as Supplier of College Data 2Elsevier Selects BrainTrack Directory as Supplier of College Data 3Elsevier Selects BrainTrack Directory as Supplier of College Data 4Welcome to the Biofuel Age of Flight 12593 1Welcome to the Biofuel Age of Flight 12593 2Welcome to the Biofuel Age of Flight 12593 3Students May Be Solution to Shortage of Medical Professionals 48719 1Students May Be Solution to Shortage of Medical Professionals 48719 2Students May Be Solution to Shortage of Medical Professionals 48719 3Students May Be Solution to Shortage of Medical Professionals 48719 4Hey Governator 21 Dont Terminate Senior Funding 21 48717 1Hey Governator 21 Dont Terminate Senior Funding 21 48717 2Hey Governator 21 Dont Terminate Senior Funding 21 48717 3Hey Governator 21 Dont Terminate Senior Funding 21 48717 4Hey Governator 21 Dont Terminate Senior Funding 21 48717 5
Other Medicine Technology:Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 2Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 3Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 4Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 5Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 6Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 7Gene Therapy Improves Vision in Patients with Congenital Retinal Disease 8BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 2BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 3BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 4BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 5BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 6BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients 7